Department of Health and Social Care’s UK Vaccine Network funding awarded to Pirbright to aid Nipah virus vaccine development
Pirbright researchers have been awarded £389,089 to develop a Nipah virus vaccine that could protect pigs and prevent disease in humans.
This funding was provided by the UK government’s UK Vaccine Network (UKVN) and will be delivered by Innovate UK. The Institute’s award is part of £10million of UK aid funding going to 22 projects advancing research into vaccines to tackle some of the world’s deadliest diseases in low- and middle-income countries. These include Nipah, Ebola, Lassa fever, Zika, Crimean-Congo haemorrhagic fever (CCHF) and Chikungunya virus.